How to Buy Profound Medical Stock
Profound Medical Corp
Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland.
Profound Medical stock last closed at $10.01, up 1.01% from the previous day, and has increased 140.05% in one year. It has overperformed other stocks in the Medical Devices industry by 1.58 percentage points. Profound Medical stock is currently +222.9% from its 52-week low of $3.10, and -35.38% from its 52-week high of $15.49.
At the moment, there are 21.26M PROF shares outstanding. The market capitalization of PROF is $212.82M. In the last 24 hours, 15,340 PROF shares were traded.
How to Buy Profound Medical Stock
Not sure how to invest in Profound Medical stock? Here's how.
- Decide where to buy Profound Medical stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Profound Medical stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Choose your payment method and add your info.
- Research Profound Medical stock: The Profound Medical ticker symbol is PROF. Is Profound Medical stock a good investment? Should you buy shares of PROF? How do PROF's underlying business fundamentals look? Do top analysts think Profound Medical is a good buy? Why has PROF's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PROF is a good stock to buy).
- Execute your PROF purchase: Decide if you will purchase PROF shares at the current market price or use a limit order to purchase PROF stock at a particular price.
- Keep an eye on your PROF investment: Create a watchlist to monitor your investment in Profound Medical stock.
Step 1: Decide where to buy Profound Medical stock
You need a brokerage account in order to access the NASDAQ market and buy PROF stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal info so you can buy PROF today.
How to Start a New Brokerage Account on eToro
- Click here to get started.
- Provide your personal details to create a new trading account.
- Send your info by pressing the "Create Account" button.
Step 3: Deposit funds into your brokerage account
Now that you have finished signing up on one of the most highly reviewed stock apps, you need to deposit funds:
Check out the video below to see the process of depositing funds into your new investment account.
Step 4: Research Profound Medical stock
After you have figured out the best place to buy Profound Medical stock, it's absolutely critical to research their stock before you buy, so you truly comprehend the risk as well as the opportunity.
Profound Medical Metrics
Fundamentals of Profound Medical
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on PROF's stock page.
What is the fair value of PROF stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge PROF's fair value.
Using relative valuations methods:
- PROF could be overvalued based on its P/B ratio of 6.33x, relative to Medical Devices industry P/B ratio of 3.54x
You can access more valuation analysis on PROF's stock here.
PROF Financial Health
Positive Health Checks:
- PROF has cash burn of 17662878. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the PROF balance sheet.
- There are more short-term assets than short-term liabilities on the PROF balance sheet.
- PROF has a low debt to equity ratio of 0.28.
Negative Health Checks:
- PROF profit margin has gone up by 2.23 percentage points in the past year, but the company is still unprofitable.
- PROF has $29.75M in cash and short term investments. This is not sufficient to cover its annual cash burn of $17.66M.
Do analysts think it's a good time to buy PROF stock
Out of 2 Equities analysts who research PROF, the consensus analyst rating on PROF is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent PROF Analyst Recommendations
Joshua Jennings, a top 24% analyst from TD Cowen maintains PROF with a buy rating and raises their PROF price target from $14.00 to $18.00, on May 11, 2023.
Ben Haynor, a bottom 1% analyst from Alliance Global Partners maintains PROF with a strong buy rating and raises their PROF price target from $13.15 to $15.75, on May 11, 2023.
You can dive deeper into what analysts are projecting on the Profound Medical stock forecast page.
Metrics for Advanced PROF Traders
Is PROF Making Money?
Last year, PROF revenue was $5.12M. In the last four year, PROF's revenue has grown by 13.12% per year. This was faster than the Medical Devices industry average of 13.02%.
You can analyze PROF's earnings and revenue performance here.
Who is buying/selling PROF?
In the past 12 months, executives and large shareholders at PROF have not bought or sold any shares.
Get more info about who owns PROF stock here.
Can I get consistent income from PROF stock?
No, Profound Medical doesn't provide an income stream by paying out dividends.
PROF Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your PROF purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open Trade button and eToro will place your order.
If you require additional help with investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your PROF investment
Now that you own some PROF shares, you'll want to keep up with your stock purchase.
Create a watchlist to see the latest developments about your PROF stock.
PROF Feed
How to Buy Stock in Profound Medical
To reiterate, here are the 6 steps to buy stock in Profound Medical:
- Decide where to buy Profound Medical stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Research Profound Medical stock
- Execute your PROF purchase
- Keep an eye on your PROF investment
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Profound Medical, create a watchlist today.
Other Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.